Evaluation and Monitoring of the Protocol Post Operative Atrial Fibrillation
ETOFIB
1 other identifier
observational
54
1 country
1
Brief Summary
Objectives The aims of this study is to evaluate the efficacy and tolerance of our post-operative AF management protocol after cardiac surgery, including beta-blockers, digoxin, amiodarone. Methods This study concerns patients From brest university Hospital who underwent cardiac surgery between November 2019 and November 2021. Patients with a previous history of atrial arrhythmias were excluded. The primary endpoint is assess effectiveness of service protocol to maintain cardiac frequency below. 110 bpm. The secondary endpoints included hemodynamic tolerance and outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2020
CompletedFirst Submitted
Initial submission to the registry
September 24, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 16, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 16, 2021
CompletedFirst Posted
Study publicly available on registry
December 21, 2021
CompletedDecember 21, 2021
December 1, 2021
1.7 years
September 24, 2020
December 14, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Heart Rate
HR \< 110 BPM
72 hours (3 days)
Secondary Outcomes (1)
sinusal Rythm
72hours ( 3 days)
Eligibility Criteria
POAF after cardiac surgery, hospitalized in ICU
You may qualify if:
- POAF after cardiac surgery non-opposition formulated
You may not qualify if:
- pregnant woman opposition hemodynamic unstability with inotropic drugs or CI\<2 L/min/m2
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHRU de Brest - Service d'anesthésie-Réanimation
Brest, 29200, France
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 24, 2020
First Posted
December 21, 2021
Study Start
February 1, 2020
Primary Completion
October 16, 2021
Study Completion
October 16, 2021
Last Updated
December 21, 2021
Record last verified: 2021-12